ADIL
ADIAL PHRMCTCLS (ADIL)
NASDAQ
$2.34-$0.02 (-1.06%)
Price as of Jun 03, 2026 4:10 PM EDT
  • $5.1M
    Market Cap
  • -85.66%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-2.6M
-18.88%
-3.2M
+154.86%
-1.3M
-69.67%
-4.2M
-50.25%
Depreciation and Amortization Expense
565
0.00%
565
+0.18%
564
0.00%
564
-0.18%
Total Operating Expenses
7.8M
-5.85%
8.3M
+20.27%
6.9M
-48.28%
13.3M
-30.96%
Operating Profit
-7.8M
-5.85%
-8.3M
+20.27%
-6.9M
-48.28%
-13.3M
-30.96%
Interest Income
149,567
-16.28%
178,659
+156.04%
69,779
+10.39%
63,209
+866.65%
Interest Expense
N/A
N/A
N/A
N/A
-175
N/A
N/A
N/A
Interest Income and Expense and Net
149,567
-16.28%
178,659
+156.68%
69,604
+10.12%
63,209
+866.65%
Total Nonoperating Income and Expense
-177,709
-96.38%
-4.9M
+4,211.80%
-113,943
-119.47%
585,209
+355.91%
Income before Taxes
-7.8M
-40.90%
-13.2M
+88.48%
-7.0M
-45.01%
-12.7M
-34.77%
Income Taxes
N/A
N/A
N/A
N/A
-746,249
+148,555.18%
-502
-99.47%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
1.5M
0.00%
Net Income
N/A
N/A
-13.2M
+157.59%
-5.1M
-59.76%
-12.7M
-34.45%
Net Income from Continuing Operations Applicable to Common
-8.0M
-39.56%
-13.2M
+88.48%
-7.0M
-45.01%
-12.7M
-34.77%
Basic EPS and Net Income
-11.93
+338.60%
-2.72
-24.44%
-3.60
+605.88%
-0.51
-50.96%
Diluted EPS and Net Income
-11.93
+338.60%
-2.72
-24.44%
-3.60
+605.88%
-0.51
-50.96%
Basic Weighted Average Shares
668,630
-86.22%
4.9M
+240.54%
1.4M
-94.31%
25.0M
+34.69%
Diluted Weighted Average Shares
668,630
-86.22%
4.9M
+240.54%
1.4M
-94.31%
25.0M
+34.69%
Balance Sheet
Cash and Cash Equivalents
5.9M
+56.81%
3.8M
+32.66%
2.8M
-29.35%
4.0M
-33.99%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5.9M
+56.81%
3.8M
+32.66%
2.8M
-29.35%
4.0M
-33.99%
Total Current Assets
6.2M
+52.28%
4.1M
+26.89%
3.2M
-33.08%
4.8M
-26.03%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
50,424
-13.28%
Total Long-Term Assets
3.4M
-2.02%
3.5M
N/A
N/A
N/A
50,424
-13.28%
Total Assets
6.7M
+32.30%
5.0M
+6.49%
4.7M
-17.38%
5.7M
-23.31%
Income Taxes Payable
N/A
N/A
0
-100.00%
7,942
-65.31%
22,897
-2.15%
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
1.4M
+43.15%
975,858
+49.42%
653,076
-63.53%
1.8M
-34.22%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
29,088
0.00%
Total Long-Term Liabilities
6.9M
+643.78%
929,156
+78.14%
521,592
+165.66%
196,341
-22.75%
Total Liabilities
1.4M
+43.15%
975,858
+49.42%
653,076
-73.41%
2.5M
-38.08%
Retained Earnings
-90.0M
+9.73%
-82.0M
+19.18%
-68.8M
+8.05%
-63.7M
+24.99%
Total Stockholders Equity
5.3M
+29.70%
4.1M
-0.38%
4.1M
+24.63%
3.3M
-6.59%
Total Shares Outstanding
1.1M
-82.84%
6.5M
+289.23%
1.7M
-93.77%
26.7M
+27.41%
Cash Flow
Cash from Operating Activities
-6.5M
-6.21%
-6.9M
+1.70%
-6.8M
-39.15%
-11.2M
-6.39%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
150,000
N/A
N/A
N/A
1.5M
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
8.5M
+8.00%
7.8M
+89.87%
4.1M
-54.72%
9.1M
-33.12%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
-269.87%
+175.74%
-97.87%
-49.23%
-192.79%
-35.65%
Return on Equity
N/A
N/A
-323.80%
+132.58%
-139.22%
-62.91%
-375.32%
-27.60%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
4.42
+6.38%
4.16
-15.08%
4.90
+83.50%
2.67
+12.45%
Cash Ratio
4.21
+9.55%
3.84
-11.22%
4.33
+93.72%
2.23
+0.35%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow